Research

A team of scientists from the German Cancer Research Center (DKFZ) and the Netherlands Cancer Institute has discovered a previously unknown vulnerability in cancer cells: When cell division is blocked with chemotherapeutic agents such as Taxol, cancer cells produce small immunogenic peptides that could open up new avenues for immune-based cancer therapies. Frequent cell division […]

Researchers identify neurotoxic protein complex – Pharmacological inhibitor opens up new perspectives for the development of effective therapies A molecular mechanism that significantly contributes to the progression of Alzheimer’s disease has been discovered by a research team led by neurobiologist Prof. Dr Hilmar Bading of Heidelberg University. In joint experiments with researchers from Shandong University […]

New study points to stem cell-like cells as the origin of persistent disease and relapses New fundamental research could help combat treatment-resistant leukaemia and prevent relapses in children and adolescents. A group of scientists studied a certain type of leukaemia and identified individual stem cell-like cells responsible for relapses in kids. They have also precisely […]

Heidelberg scientists develop AI model for producing new molecular machines in a targeted way The targeted engineering of artificial proteins with unique properties – that is possible with the assistance of a novel method developed by a research team led by Prof. Dr Dominik Niopek at the Institute of Pharmacy and Molecular Biotechnology (IPMB) of […]

The team at Heidelberg University Hospital’s Department of Urology, led by its new Medical Director Professor Johannes Huber, has introduced a new imaging technique called micro-ultrasound to assist with prostate biopsies in Heidelberg. This technique allows even the smallest tissue abnormalities to be targeted with great precision. Another advantage for patients is that magnetic resonance […]

Merck announced that the European Commission granted approval for Ogsiveo for the treatment of adults with desmoid tumors. 18 Aug 2025 | Darmstadt, Germany Merck, a leading science and technology company, announced today that the European Commission (EC) granted marketing authorization for OGSIVEO® (nirogacestat), an oral gamma secretase inhibitor, as monotherapy for the treatment of adults with progressing […]

Every brain tumor is made up of cells in successive stages of activation. Researchers at the German Cancer Research Center (DKFZ) and Heidelberg University have now analyzed the individual structure of these activation pyramids in malignant brain tumors for the first time. In doing so, they discovered a signaling protein that slows down the transition […]

The Dietmar Hopp Foundation is supporting the establishment of an experimental production unit for gene therapies for the heart at Heidelberg University’s Medical Faculty, in the Department of Cardiology, Angiology, and Pneumology at Heidelberg University Hospital (UKHD). The new production capacities for therapeutic viruses, the “gene taxis” to the diseased heart, strengthen the pioneering role […]

Fabulous accelerates antibody discovery with a fully computational, AI-powered approach that delivers preclinical ready human antibodies in just 3–5 days. Starting from your scientific problem, it designs candidates using curated human sequence data and in silico maturation to mimic natural immune evolution. This process enhances affinity, thermostability, and expression while reducing off-target binding. Each sequence […]